Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
A brief guide to blue chip alternatives beyond BTC and ETH, highlighting characteristics that define blue chip status and potential rewards.
20,411 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
A big fund move can shift sentiment and pricing. This article breaks down the implications of baillie gifford dumps 2...
An investor's guide to the early signals from hims 2026 earnings. We break down Q1 results, margins, and what they me...
A family estate in a hot real estate market yields a six-figure tax surprise when an inherited home’s stepped-up basi...
Despite the everyday label of 'dull,' transportation stocks move goods and markets. In 2026, two names shine with str...
Elon Musk touched down in Beijing as the OpenAI trial with Sam Altman reaches its closing phase. A California judge w...
As Trump meets with Xi, the U.S.-China relationship enters a peer-level phase. Security experts warn Beijing now sees...
A SpaceX public listing could ripple across technology, energy, and investing. Learn how NuScale Power stands to gain...
As U.S. markets face volatility, a single low-cost ETF offering broad exposure to Europe and Japan is drawing steady ...
NextEra Energy is pursuing a $67 billion all-stock deal to buy Dominion, aiming to create the world’s largest utility...
Goldman Sachs researchers contend that the U.S. labor market has improved since ChatGPT first opened its chat window,...
Stifel boosted CrowdStrike’s target to $660 ahead of the June earnings release, signaling renewed optimism on growth ...